By comparing them, we could observe if EMF primarily interferes with passive diffusion (E. coli) or active ejection (P. aeruginosa).
This multi-factorial approach ensures that physical field effects and polymer-based delivery work in tandem to systematically dismantle bacterial survival pathways9.
A recurring pattern in this study is the existence of highly specific biological frequency windows61,62.
Electromagnetic fields must induce dielectric polarization within this dense matrix to loosen the molecular sieve and facilitate nanoparticle influx32.
The oscillating physical fields exert localized Lorentz forces and induce dielectric polarization across these highly charged functional groups.
The selection of S. aureus, E. coli, and P. aeruginosa was strategically designed to evaluate whether the observed bioelectric phenomena are universal or dependent on specific cell envelope architectures. S. aureus was utilized as the most standard for Gram-positive research. Its monoderm architecture characterized by a thick (20–80 nm), robust peptidoglycan layer lacking an outer membrane serves as a sufficient model to study how electromagnetic fields (EMF) penetrate dense, porous cell walls52. While both E. coli and P. aeruginosa are Gram-negative, they were both included to address the massive disparity in their physical and chemical resistance profiles. E. coli represents a standard, relatively permeable model where drug entry occurs via common porin channels53. In contrast, P. aeruginosa serves as a fortified model; its outer membrane is 10 to 100 times less permeable than that of E. coli54. This dual strain approach allowed us to determine if EMF treatment can facilitate drug delivery in both standard and highly resistant physiological environments. The two Gram-negative strains offer distinct insights into antibiotic-field interactions. While E. coli resistance is primarily enzymatic (mutations in DNA gyrase), P. aeruginosa utilizes aggressive active ejection via efflux pumps such as MexAB-OprM system55. By comparing them, we could observe if EMF primarily interferes with passive diffusion (E. coli) or active ejection (P. aeruginosa).
The transition in the physical profiles of the nanoparticles post-loading specifically the increase in particle size from 122 ± 1.2 nm to 160 ± 2.6 nm and the shift in PDI from 0.22 ± 0.04 to 0.34 ± 0.06 offers distinct functional advantages across multiple biophysical parameters. From a structural standpoint, the enlargement from 122 nm to 160 nm directly reflects successful core drug loading, facilitating an exceptionally high encapsulation efficiency (97 ± 0.57%) by creating an optimal volume-to-core ratio within the cross-linked chitosan-TPP matrix. Biologically, a particle size of 160 nm is highly advantageous for controlled release behavior; it avoids the rapid burst release typical of smaller nanostructures by lengthening the diffusion pathway of ciprofloxacin out of the polymer core, ensuring sustained delivery at the infection site. Furthermore, despite the moderate increase in PDI to 0.34, the system maintains a zeta potential of + 40 ± 2.51 mV, which provides strong electrostatic repulsion to preserve long-term colloidal stability and prevent spontaneous aggregation in solution. This controlled size profile is perfectly optimized for biomedical applications; it falls within the ideal window to ensure high antibacterial efficacy by maximizing localized drug retention while being large enough to limit non-specific mammalian cellular uptake, thus minimizing systemic toxicity.
Importantly, the particle size obtained in this study, along with the observed positive zeta potential, aligns closely with the characteristics of previously documented antimicrobial nanomaterials. These nanomaterials have demonstrated a significant ability to interact with the surfaces of bacterial cells, leading to increased effectiveness in combating resistant pathogens11. This enhanced interaction is crucial for improving antimicrobial efficacy, as it allows for better penetration and disruption of bacterial cell membranes, ultimately resulting in a more potent antimicrobial response11,12. When evaluated against broader microbiological benchmarks, these characterization metrics and the resulting MIC reductions parallel recent nano-enabled antimicrobial strategies targeted at multidrug-resistant (MDR) ESKAPE pathogens. Previous studies optimizing metal oxide and polymeric nanoparticles against highly defensive strains like P. aeruginosa and S. aureus demonstrate that controlling the nanostructure’s physical presentation is a prerequisite to overcoming adaptive envelope barriers9,56. By achieving a highly uniform distribution that sits comfortably within these established structural windows, our system successfully mirrors the baseline efficacy seen in state-of-the-art ESKAPE-targeted platforms, validating its deployment against highly resistant clinical isolates.
The primary mechanism observed across all species is the bioelectric effect, driven by the application of PEF. This phenomenon describes a multi-stage interaction where the external field actively modifies both the structural integrity of the biofilm matrix and the physiological state of the bacterial cells51,57. PEF acts as a physical “permeabilizer,” inducing dielectric breakdown and the formation of transient, nanometer-sized pores within the lipid bilayer58. This electromechanical stress destabilizes the transmembrane potential (Vm), which can be modeled by the Goldman Hodgkin Katz (GHK) Voltage Equation. By increasing effective porin size and membrane permeability, PEF allows Cipro-C-NPs to bypass physical defenses and reach intracellular targets specifically DNA gyrase more efficiently59. Nevertheless, it is crucial to recognize that the overall antimicrobial mechanisms associated with these advanced nanoparticles are highly complex and arise from multiple interconnected factors beyond physical pore formation. In addition to improved membrane permeability, antimicrobial nanomaterials can exert their cytotoxic effects through the generation of ROS that induce oxidative stress, the direct chemical destabilization of lipid bilayers, the inhibition of quorum sensing networks, structural damage to vital intracellular proteins, and the targeted down-regulation or suppression of biofilm-related genes60. This multi-factorial approach ensures that physical field effects and polymer-based delivery work in tandem to systematically dismantle bacterial survival pathways9.
A recurring pattern in this study is the existence of highly specific biological frequency windows61,62. While PEF provides direct physical disruption, PMF operate primarily via a resonance mechanism. In E. coli, synergy was restricted to 0.7 Hz. In S. aureus, synergy was observed at 20 Hz (PMF) and 6 Hz (PEF). This suggests that specific frequencies match the natural oscillation of membrane-bound proteins, ion pumps, or teichoic acids63. In some instances, such as with E. coli and P. aeruginosa, PMF induced resonance may over stimulate active efflux systems (AcrAB-TolC pump), physically expelling antibiotics before they reach their target.
The variability in antimicrobial response is rooted in the fundamental differences in bacterial architecture in a way that it shows Gram-Negative barrier or Gram-Positive resilience. E. coli possesses a permeable outer membrane that is highly susceptible to pore formation. In contrast, P. aeruginosa is 10 to 100 times less permeable and produces alginate exopolysaccharides54. This thick dielectric environment can act as a physical shield, requiring specific resonance (20 Hz) to reach the threshold necessary to interfere with intracellular targets62. On the other hand, the thick, cross linked peptidoglycan layer of S. aureus acts as a protective buffer52. Electromagnetic fields must induce dielectric polarization within this dense matrix to loosen the molecular sieve and facilitate nanoparticle influx32.
Electromagnetic stress disrupts the collective behavior of bacterial populations through quorum quenching and virulence modulation. PMF induced magnetokinetic stress likely disrupts the ionic environments or conformational stability of receptor proteins (LasR/RhlR) required for signal transduction63. This silencing of communication was most evident in P. aeruginosa, where PMF exposure completely abolished the production of the redox-active virulence factor pyocyanin. This robust suppression of key virulence traits has profound implications for reducing bacterial pathogenicity and mitigating the development of resistance. By non-invasively disrupting the production of pyocyanin and down-regulating signaling networks, the treatment actively disarms the pathogen’s biochemical weaponry without immediately threatening its basic survival. This specific attenuation limits the selective evolutionary pressure that typically drives mutations and adaptive resistance during aggressive, high-dose antibiotic regimens. Furthermore, neutralizing these virulence factors directly impairs the structural stabilization of the extracellular matrix, leaving the bacterial population highly vulnerable to host immune clearance and concurrent antibiotic action.
Similarly, the reduction of N-acyl homoserine lactone (AHL) signaling molecules prevents biofilms from reaching structural maturity64. Disrupting biofilms is a crucial therapeutic target since mature biofilms shield bacterial communities from antibiotics and immune responses, acting as a primary driver of phenotypic antimicrobial resistance56. Antimicrobials derived from natural products and nanomaterials have demonstrated significant potential in preventing the establishment and maturation of biofilms11. The consistent reduction in biofilm formation across most conditions highlights a fitness trade off. The metabolic cost of maintaining robust adaptive resistance mechanisms and a thick peptidoglycan layer under physical stress diverts the energy budget away from biofilm-associated protein synthesis65. Furthermore, PEF-induced structural perturbations of surface appendages like fimbriae and pili prevent the transition from a planktonic state to a sessile biofilm community. However, the wide range of biofilm inhibition observed across different exposure regimes such as in S. aureus, where responses varied from a negligible 4% to a robust 45% inhibition highlights the highly non-linear nature of bioelectromagnetic interactions. Rather than indicating stochastic instability or poor reproducibility, this high sensitivity to specific combinations of frequency and duration reflects the existence of narrow, discrete “biophysical windows” of efficacy. In a clinical or translational setting, this underscores that physical field treatments cannot be applied as broad, generalized exposures. Instead, they require strict protocol standardization and precise parameter lock-in. Just as specific dosages are vital for pharmaceuticals, identifying and fixing the exact therapeutic “sweet spots” (such as the specific synergistic frequencies identified in this screening) is an absolute prerequisite to achieving reproducible clinical outcomes.
This non-linear behavior is further illustrated by the notable observation in Fig. 9, where Chitosan NPs demonstrated a superior standalone antibiofilm effect compared to the drug-loaded Cipro-C-NPs. This phenomenon is driven by the intrinsic, highly polycationic nature of pure chitosan, which possesses a high density of unoccupied protonated amino groups (NH 3 +). These positive charges interact directly and aggressively with the negatively charged components of the bacterial extracellular polymeric substance (EPS) matrix such as alginate and extracellular DNA (eDNA) causing severe electrostatic destabilization and structural collapse of the biofilm shield. Conversely, when chitosan is loaded with Ciprofloxacin, a portion of these active cationic amino groups undergoes partial neutralization through ionic interactions with the drug molecules, as confirmed by the lower baseline zeta potential observed during characterization. This charge utilization, combined with modified drug release kinetics within the dense matrix, slightly dampens the immediate, surface-mediated electrostatic disruption of the biofilm compared to the fully exposed positive charge of the nanoparticles.
To understand the molecular vulnerability of the delivery system to external fields, the fundamental nature of the drug-polymer matrix must be examined. The exceptionally high encapsulation efficiency observed is dictated by strong electrostatic and ionic interactions between the protonated primary amino groups (NH 3 +) along the chitosan backbone and the deprotonated carboxylate groups (COO-) of the zwitterionic ciprofloxacin molecule. When exposed to extremely low-frequency electromagnetic fields, this localized electrostatic equilibrium is actively perturbed. The oscillating physical fields exert localized Lorentz forces and induce dielectric polarization across these highly charged functional groups. This electromagnetic stress generates microscopic structural torque and molecular vibrations that temporarily weaken the ionic attraction and hydrogen bonding network holding the drug within the polymeric mesh. Consequently, exposure to physical fields can directly modulate the structural stability of the matrix, altering drug-binding efficiency and driving accelerated or altered drug-release kinetics depending on the specific frequency applied. Under synergistic parameters, this field-induced disruption acts as a physical trigger that commandingly accelerates drug liberation to overwhelm bacterial defenses; conversely, under poorly calibrated regimes, the disruption of this internal electrostatic balance leads to the surface charge rearrangements and subsequent colloidal aggregation observed elsewhere in our study.
